RECRUITING

Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to develop a new noninvasive tool for early diagnosis of Peripheral Arterial Disease (PAD) and use the proposed method for monitoring the disease progression and the response to interventional treatment in PAD patients.

Official Title

Ultrasound Perfusion Estimation for Assessment of PAD

Quick Facts

Study Start:2025-03-14

Study Completion:2029-08-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06952543

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Male and Female, ages 18 years old and up * Symptom of claudication and suspected for PAD * Scheduled for vascular testing. * Male and female, ages 18-75 years old and up * Normal BMI * No history of smoking, cardiovascular disease, or diabetes.	* Patients with gangrene * Patients having surgery or stent * Patients with ulcer on their leg * Any health condition that does not allow proper use of ultrasound scanning * People considered in "vulnerable" populations. * Include volunteers with BMI not more than 30 * No history of smoking * No history of (diabetes, hypertension, cardiovascular diseases) * People considered in "vulnerable" populations.

Inclusion Criteria

Exclusion Criteria

* Male and Female, ages 18 years old and up
* Symptom of claudication and suspected for PAD
* Scheduled for vascular testing.
* Male and female, ages 18-75 years old and up
* Normal BMI
* No history of smoking, cardiovascular disease, or diabetes.

* Patients with gangrene
* Patients having surgery or stent
* Patients with ulcer on their leg
* Any health condition that does not allow proper use of ultrasound scanning
* People considered in "vulnerable" populations.
* Include volunteers with BMI not more than 30
* No history of smoking
* No history of (diabetes, hypertension, cardiovascular diseases)
* People considered in "vulnerable" populations.

Contacts and Locations

Principal Investigator

Azra Alizad

PRINCIPAL_INVESTIGATOR

Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

United States

Collaborators and Investigators

Sponsor: Mayo Clinic

Azra Alizad, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-14

Study Completion Date2029-08-30

Study Record Updates

Study Start Date2025-03-14

Study Completion Date2029-08-30

Terms related to this study

Additional Relevant MeSH Terms

Peripheral Arterial Disease